Research Catalog
New! Try our Article Search to discover online journals, books, and more from home with your library card.
Displaying 1-50 of 265 results
Burger's medicinal chemistry and drug discovery.
- Text
- Hoboken, N.J. : Wiley, c2003.
- 2003
- 12 Items
Available Online
http://www.loc.gov/catdir/toc/wiley031/2002044608.htmlItem details Format Call Number Item Location Text JSM 03-48 v. 5 Offsite Item details Format Call Number Item Location Text JSM 03-48 Library has: Vol. 1-6. Schwarzman Building - Main Reading Room 315 Not available - Please for assistance.Item details Format Call Number Item Location Text JSM 03-48 v. 6 Offsite Innovation in the pharmaceutical industry : the process of drug discovery and development / Takuji Hara.
- Text
- Cheltenham, UK ; Northampton, MA : Edward Elgar, c2003.
- 2003
- 1 Item
Item details Format Call Number Item Location Text JBE 03-1389 Offsite Development and evaluation of drugs : from laboratory through licensure to market / Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu.
- Text
- Boca Raton : CRC Press, c2003.
- 2003
- 1 Item
Item details Format Call Number Item Location Text JBE 04-1805 Offsite Drug discovery and development / edited by Mukund S. Chorghade.
- Text
- Hoboken, N.J. : Wiley-Interscience, c2006-
- 2006-2007
- 2 Items
Available Online
http://www.loc.gov/catdir/toc/ecip0516/2005021297.htmlItem details Format Call Number Item Location Text JBF 18-498 v. 1 Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Item details Format Call Number Item Location Text JBF 18-498 v. 2 Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Drug discovery : from bedside to Wall Street / by Tamas Bartfai, Graham V. Lees.
- Text
- Amsterdam ; Boston : Elsevier Academic, c2006.
- 2006
- 1 Item
Item details Format Call Number Item Location Text JBE 06-602 Offsite Dose finding in drug development / Naitee Ting, editor.
- Text
- New York, NY : Springer, c2006.
- 2006
- 1 Item
Available Online
http://www.loc.gov/catdir/toc/fy0606/2005935288.htmlItem details Format Call Number Item Location Text JBE 06-1065 Offsite American drug discovery.
- Text
- Indianapolis, Ind. : Russell Pub., 2006-
- 2006-present
- 1 Item
Item details Format Call Number Item Location Text JBM 08-181 v. 3, no. 1, 3-6 (Dec-Nov 2007-2008) Offsite Biochips as pathways to drug discovery / edited by Andrew Carmen, Gary Hardiman.
- Text
- Boca Raton, FL : CRC Press/Taylor & Francis, c2007.
- 2007
- 1 Item
Item details Format Call Number Item Location Text JSE 07-608 Offsite In silico technologies in drug target identification and validation / edited by Darryl León, Scott Markel.
- Text
- Boca Raton : CRC/Taylor & Francis, c2006.
- 2006
- 1 Item
Available Online
http://www.loc.gov/catdir/toc/ecip068/2006005722.htmlItem details Format Call Number Item Location Text JSE 07-1131 Offsite Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
- 2008
- 2 Resources
Available Online
See All Available Online Resources
Innovation in the biopharmaceutical industry / editors, Rifat A. Atun, Desmond Sheridan.
- Text
- Hackensack, N.J. : World Scientific Pub., c2007.
- 2007
- 1 Item
Available Online
http://www.loc.gov/catdir/toc/ecip0710/2007004943.htmlItem details Format Call Number Item Location Text JSF 08-332 Offsite Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
- Text
- Washington : U.S. G.P.O., 2008.
- 2008
- 2 Resources
Available Online
See All Available Online Resources
Outsourcing clinical development : strategies for working with CROs and other partners / edited by Jane E. Winter and Jane Baguley.
- Text
- Aldershot, England ; Burlington, VT : Gower Pub., c2006.
- 2006
- 1 Item
Item details Format Call Number Item Location Text JBG 09-171 Offsite E2f development safety update report.
- Text
- [Silver Spring, MD] : [Center for Drug Evaluation and Research] ; [Rockville, MD] : [U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research], [2008]
- 2008
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS111600Information sheet guidance for sponsors, clinical investigators, and IRBs : frequently asked questions, statement of investigator (form FDA 1572).
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, [2008]
- 2008
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS111644Guidance for industry : community-acquired bacterial pneumonia : developing drugs for treatment.
- Text
- Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
- 2009
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS112221Guidance for industry : influenza, developing drugs for treatment and/or prophylaxis.
- Text
- Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
- 2009
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS112225Guidance for industry and FDA : current good manufacturing practice for combination products.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products, [2004]
- 2004
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS112968Guidance for industry and FDA staff [electronic resource] : early development considerations for innovative combination products.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products, [2006]
- 2006
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS113681Guidance for industry [electronic resource] : Q3A impurities in new drug substances.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2008]
- 2008
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS113736Guidance for industry [electronic resource] : fast track drug development programs, designation, development and application review.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2006]
- 2006
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS113471Guidance for industry [electronic resource] : Q3B(R2) impurities in new drug products.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
- 2006
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS113762Guidance for industry [electronic resource] : E2E pharmacovigilance planning.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2005]
- 2005
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS113917Q8(R1) pharmaceutical development revision 1 [electronic resource].
- Text
- [Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2008?]
- 2008
- 1 Item
Item details Format Call Number Item Location Text Check with Staff Not available - Please for assistance.1570 : innovation for new medicines for infectious diseases.
- Text
- Paris : OECD, c2009.
- 2009
- 1 Item
Available Online
http://www.sourceoecd.org/9789264060142Item details Format Call Number Item Location Text JBE 09-1570 Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Guidance : PET drug products, current good manufacturing practice (CGMP).
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2005]
- 2005
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS116533Guidance for industry : Q8(R2) pharmaceutical development.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2009]
- 2009
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS117887Biologics and biosimilars [microform] : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2010.
- 2010
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases [microform] : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011.
- 2011
PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
- Text
- Washington : U.S. G.P.O., 2012.
- 2012
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo26461Q8(R1) pharmaceutical development revision 1 [electronic resource].
- Text
- [Rockville, MD] : [U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research] : [Center for Biologics Evaluation and Research], [2008?]
- 2008
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS113761The high cost of high prices for HIV/AIDS drugs and the prize fund alternative : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... May 15, 2012.
- Text
- Washington : U.S. G.P.O., 2012.
- 2012
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo30915Curtis Powell papers, 1935-2002 (bulk 1968-2002).
- Mixed material
- 1935-2002
- 2 Items
Available Online
http://archives.nypl.org/scm/22377Item details Format Call Number Item Location Mixed material Sc MG 877 box 1 Schomburg Center - Manuscripts & Archives Available - Can be used on site. Please visit New York Public Library - Schomburg Center to submit a request in person.
Item details Format Call Number Item Location Mixed material Sc MG 877 box 2 Schomburg Center - Manuscripts & Archives Available - Can be used on site. Please visit New York Public Library - Schomburg Center to submit a request in person.
Les hommes et les plantes : valorisation des ressources de la médecine traditionnelle à Kadiolo (Mali) / Sergio Giani.
- Text
- Bamako : EDIMCO MALI, 2010.
- 2010
- 1 Item
Item details Format Call Number Item Location Text Sc E 13-622 Offsite The pharmaceutical industry [electronic resource] / Jamuna Carroll, book editor.
- Text
- Detroit : Greenhaven Press, c2009.
- 2009
- 2 Resources
Available Online
See All Available Online Resources
FDA checkup : drug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013.
- Text
- Washington : U.S. Government Printing Office, 2014.
- 2014
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo49004Conservatism, consumer choice, and the Food and Drug Administration during the Reagan era : a prescription for scandal / Lucas Richert.
- Text
- Lanham, Maryland ; Plymouth, United Kingdom : Lexington Books, [2014]
- 2014
- 1 Item
Item details Format Call Number Item Location Text JFE 14-5708 Schwarzman Building - Main Reading Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
FDA checkup : drug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013.
- Text
- [Washington, District of Columbia] : U.S. Government Printing Office, [2014]
- 2014
Medical monopoly : intellectual property rights and the origins of the modern pharmaceutical industry / Joseph M. Gabriel.
- Text
- Chicago : The University of Chicago Press, [2014]
- 2014-2014
- 1 Item
Item details Format Call Number Item Location Text JFE 14-8232 Schwarzman Building - Main Reading Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
- Text
- [Washington, District of Columbia] : U.S. Government Printing Office, [2012]
- 2012
Twenty-first century cures : examining the roles of incentives in advancing treatments and cures for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, June 11, 2014.
- Text
- Washington : U.S. Government Printing Office, 2014.
- 2014
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo54770The high cost of high prices for HIV/AIDS drugs and the prize fund alternative : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session on ... S. 1137 ... and S. 1138 ... May 15, 2012.
- Text
- Washington : U.S. Government Printing Office, 2012.
- 2012
21st century cures : the President's Council of Advisors on Science and Technology (PCAST) report on drug innovation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, May 20, 2014.
- Text
- Washington : U.S. Government Publishing Office, 2015.
- 2015
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo5561021st century cures : incorporating the patient perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 11, 2014.
- Text
- Washington : U.S. Government Publishing Office, 2015.
- 2015
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo56008Twenty-first century cures : examining the roles of incentives in advancing treatments and cures for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, June 11, 2014.
- Text
- Washington : U.S. Government Printing Office, 2014.
- 2014
21st century cures : the President's Council of Advisors on Science and Technology (PCAST) report on drug innovation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, May 20, 2014.
- Text
- Washington : U.S. Government Publishing Office, 2015.
- 2015
21st century cures : incorporating the patient perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 11, 2014.
- Text
- Washington : U.S. Government Publishing Office, 2015.
- 2015
21st Century Cures Act : report of the Committee on Energy and Commerce, House of Representatives (to accompany H.R. 6).
- Text
- [Washington, D.C.] : [U.S. Government Publishing Office], [2015]-
- 2015-present
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo5891721st Century Cures Act : report of the Committee on Energy and Commerce, House of Representatives (to accompany H.R. 6).
- Text
- [Washington, D.C.] : [U.S. Government Publishing Office], [2015]-
- 2015-present
No results found from Digital Research Books Beta
Digital books for research from multiple sources world wide- all free to read, download, and keep. No Library Card is Required. Read more about the project.
